Rankings
▼
Calendar
FLGT FY 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
FY 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$289M
-53.3% YoY
Gross Profit
$104M
36.1% margin
Operating Income
-$196M
-67.6% margin
Net Income
-$168M
-58.0% margin
EPS (Diluted)
$-5.63
Cash Flow
Operating Cash Flow
$27M
Free Cash Flow
$5M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$102M
Stockholders' Equity
$1.1B
Cash & Equivalents
$97M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$289M
$619M
-53.3%
Gross Profit
$104M
$367M
-71.5%
Operating Income
-$196M
$179M
-209.5%
Net Income
-$168M
$143M
-217.0%
← Q4 2022
All Quarters
Q1 2023 →